Clinical Trials Logo
  1. Home
  2. Variceal Hemorrhage
  3. NCT03891849

Macro and Microcirculatory Effects of the Combination of Norepinephrine and Octreotide for the Treatment of Cirrhotic Patients With Hemorrhagic Shock — HemodyNoOc  

Variceal Hemorrhage Clinical Trial

Official title:
Macro and Microcirculatory Effects of the Combination of Norepinephrine and Octreotide for the Treatment of Cirrhotic Patients With Hemorrhagic Shock

Clinical Trial Summary

Octreotide is used to decrease portal pressure of cirrhotic patients admitted for variceal bleeding. When patients are in haemorrhagic shock, the recommended drug to increase arterial pressure is norepinephrine. Microcirculatory effects of octreotide when it is added to noradrenaline has not been investigated yet. The aim of the study is to evaluate the effect of octreotide plus norepinephrine for patient with haemorrhagic shock after variceal bleeding.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03891849
Study type Interventional
Source Centre Hospitalier Universitaire, Amiens
Contact
Status Withdrawn
Phase N/A
Start date September 1, 2021
Completion date May 2023
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04546360 - Spleen Stiffness Combined With Liver Stiffness Measured by 2D-SWE for the Screening of High-risk Varices in Compensated Advanced Chronic Liver Disease (CHESS2004)
Not yet recruiting NCT06027970 - Efficacy of Continuous Terlipressin Therapy After Endoscopic Variceal Ligation Phase 3
Completed NCT03061604 - RCT to Determine the Efficacy of Combining Hemospray With Medical Treatment in Acute Variceal Bleeding N/A
Recruiting NCT05124041 - Goal-Directed Hemostatic Resuscitation Trial in ACLF Induced Coagulopathy N/A
Recruiting NCT04111120 - Heparin Like Effect in Acute Variceal Bleeding
Completed NCT03459378 - Outcome After TIPS
Not yet recruiting NCT06325436 - Objective Scores in Variceal Bleeding
Completed NCT03846180 - Terlipressin on Effect of Renal Function in Cirrhotic Patients With Acute Gastrointestinal Hemorrhage
Not yet recruiting NCT04254822 - HVPG-Guided Therapy vs Carvedilol Plus Endotherapy for the Prevention of Esophageal Variceal Rebleeding in Cirrhotic Patients N/A
Not yet recruiting NCT04207398 - TIPS vs. NSBB Plus Endotherapy for the Prevention of Variceal Rebleeding in NSBB Non-responders of Primary Prophylaxis N/A
Recruiting NCT05872698 - Beta-blockers or Placebo for Primary Prophylaxis (BOPPP) of Oesophageal Varices Trial. Phase 4
Not yet recruiting NCT03130127 - Continuous Versus Bolus Infusion of Terlipressin for Portal Hypertension Related Bleeding in Liver Cirrhosis N/A
Recruiting NCT03720067 - Propranolol, Carvedilol and Rosuvastatin in the Prevention of Variceal Bleeding in Cirrhotic Portal Hypertension Phase 2/Phase 3
Completed NCT01783899 - Clinical Evaluation of Hemospray in Hemostasis of Active Variceal Bleeding N/A
Completed NCT00825877 - Long-term Follow-up of HALT-C Sustained Virological Responders
Completed NCT05227833 - Vonoprazan Efficacy to Prevent Post Variceal Band Ligation Ulcer Phase 3
Recruiting NCT03267615 - VICIS - Vienna Cirrhosis Study
Recruiting NCT04640350 - Risk Prediction of Bleeding in Liver Cirrhosis by Combi-elastography
Not yet recruiting NCT01371591 - Capsule Endoscopy for Hemorrhage in the Emergency Room N/A